News
"Is Now the Time to Build in China?" – Bluestar Publishes Article Analyzing China Pharmaceutical Market Entry Strategies
The Bluestar team has been assisting US companies interested in learning about the evolving pharmaceutical market in China, and advising on cross-border business development initiatives. We have distilled key observations from recent market trends and written an in-depth paper on the topic of “build” vs. “rent” in China. It is published in the Oct 7, 2021 issue of In Vivo, an Informa Pharma Intelligence publication.
Paul Zhang Hosts China Innovative Pharma Panel at the 2021 China Focus Conference
On January 10, 2021, Paul Zhang, Partner at Bluestar BioAdvisors LLC hosted a panel discussion titled “The Dawn of Innovative Pharmaceutical Market in China” during the annual China Focus conference, which took place simultaneously with the 39th virtual JP Morgan Healthcare Conference. Paul was joined by the following senior leaders of four innovative Chinese biotechnology companies ...
Paul Zhang Hosts U.S./China Licensing Due Diligence Panel at the 2020 LES Annual Conference
On October 20, 2020, Paul Zhang, Partner at Bluestar BioAdvisors LLC hosted a panel discussion titled “Due Diligence Best Practices: U.S./China Cross-Border Licensing Agreements” during the North American Licensing Executives Society (LES)’s annual meeting. Paul was joined by an all-star cast of panelists ...
Paul Zhang Serves as a China Expert at SVB Leerink’s Affordable Medicines Forum
On October 16, 2020, Paul Zhang, Partner at Bluestar BioAdvisors LLC was an expert guest in a virtual “fireside chat” titled “China Market: Promises & Misconceptions”, hosted by SVB Leerink biotechnology analyst Ami Fadia during the Affordable Medicines Forum for investors ...
Monika Trzcinska participates in life sciences consulting panel at Harvard GSAS Consulting Club
On April 16, 2020, Monika Trzcinska, Partner at Bluestar BioAdvisors, LLC (Bluestar) joined the Life Sciences Consulting panel hosted by the Harvard GSAS Club, a student organization that provides educational programs and helps to bridge the gap between industry and academia ...
Monika Trzcinska participates in Women in Consulting Panel at Harvard GSAS Consulting Club; Paul Zhang serves as a judge in the annual case competition at Yale Graduate Consulting Club
On March 19, 2020, Monika Trzcinska, Partner at Bluestar BioAdvisors, LLC (Bluestar) joined the Women in Consulting panel hosted by the Harvard GSAS Club ... On March 20, 2020, Paul Zhang, Partner at Bluestar, joined the annual case competition hosted by the Yale Graduate Consulting Club (YGCC) ...
Paul Zhang moderates panel discussion during JPM Week 2020
Paul Zhang, Partner at Bluestar BioAdvisors LLC, led a panel discussion at the China Focus Forum on January 12 in San Francisco, leading up to the JP Morgan Healthcare conference 2020 ...
Bluestar BioAdvisors welcomes Erin Olsen as Managing Director
Bluestar BioAdvisors announced today that Erin Olsen has been named as a Managing Director of the firm. She joins Darren Eskow, Monika Trzcinska, and Paul Zhang as part of the Bluestar leadership team ...
Bluestar BioAdvisors welcomes Paul Zhang as Partner
Bluestar BioAdvisors announced today that Paul Zhang has been named as a Partner of the firm. He joins Darren Eskow and Monika Trzcinska as the Operating Partners of Bluestar ...
The consulting business of Torreya Insights spins out into a new entity - Bluestar BioAdvisors, LLC
The consulting team from Torreya Insights has spun out into a new entity called Bluestar BioAdvisors, LLC. (“Bluestar”). A boutique, client-centered consulting firm specializing in the life sciences industry, Bluestar will be led by co-founders and Managing Directors ...